SCHEMBL6656950

SCHEMBL6656950

O=C1CCc2ccccc2N1CO

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.65
CHRM2 P08172 11/20 0.52
CHRM4 P08173 11/20 0.52
CHRM5 P08912 11/20 0.52
CHRM1 P11229 11/20 0.52
CHRM3 P20309 11/20 0.52
DRD2 P14416 9/20 0.52
DRD4 P21917 9/20 0.52
DRD3 P35462 9/20 0.52
MAPT P10636 3/20 0.50
TP53 P04637 2/20 0.50
ADRB2 P07550 1/20 0.50
ADRB1 P08588 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
THRB P10828 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30460612 1.00 POLB (0.65) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL14277003 0.86 POLB (0.61) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL17969134 0.83 POLB (0.67) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL2954869 0.83 HTR7 (0.53) POLBDRD2DRD4DRD3
SCHEMBL5661091 0.83 CHRM2 (0.67) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL8556193 0.81 POLB (0.65) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL29525493 0.81 POLB (0.65) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL933584 0.81 POLB (0.64) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL29456062 0.81 POLB (0.64) POLBCHRM2CHRM4CHRM5CHRM1
SCHEMBL3785481 0.80 POLB (0.58) POLBCHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103974948-A Substituted benzyl indazoles as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Bayer Pharma AG 2014-08-06 CN disclosed
CN-102239159-B 7-piperidinoalkyl-3,4-dihydroquinolone derivative TAISHO PHARMACEUTICAL CO LTD 2014-06-25 CN disclosed
CN-101754761-B Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents REVIVA PHARMACEUTICALS INC 2014-06-18 CN disclosed
EP-1470126-A1 N-SUBSTITUTED SPIROPIPERIDINE COMPOUNDS AS LIGANDS FOR ORL-1 RECEPTOR PFIZER INC. (US) 2004-10-27 EP disclosed
WO-2003064425-A1 N-SUBSTITUTED SPIROPIPERIDINE COMPOUNDS AS LIGANDS FOR ORL-1 RECEPTOR PFIZER JAPAN INC. (JP) 2003-08-07 WO disclosed